Clinical trial
Cidofovir in Renal Transplant Recipients With BKVN
NCT00138424 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00138424 |
|---|---|
| Title | Cidofovir in Renal Transplant Recipients With BKVN |
| Official title | A Randomized, Placebo-Controlled, Dose-Escalation Study to Assess the Safety and Effect of Cidofovir in Renal Transplant Recipients With BK Virus Nephropathy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | BK Virus (Nephropathy) |
| Intervention type | Drug |
| Interventions | Cidofovir, Placebo |
| Enrollment | 22 |
| Start date | May 1, 2006 |
| Primary completion | Jun 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Aug 30, 2005 |
| Last update posted | Mar 8, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: